132 related articles for article (PubMed ID: 22553708)
1. Expression of MMP-2 and MMP-9 in retinoblastoma and their significance.
Long H; Zhou B; Jiang FG
Int J Ophthalmol; 2011; 4(5):489-91. PubMed ID: 22553708
[TBL] [Abstract][Full Text] [Related]
2. [Expression of matrix metalloproteinase-2,matrix metalloproteinase-9 and vascular endothdial growth factor in retinoblastoma and its clinical significance].
Zhou L; Xu J; Kang J
Yan Ke Xue Bao; 2010 Aug; 25(1):62-4. PubMed ID: 21166045
[TBL] [Abstract][Full Text] [Related]
3. Correlations between claudin-1 and PIGF expressions in retinoblastoma.
Wang HF; Zheng SF; Chen Y; Zhou ZY; Xu J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4196-4203. PubMed ID: 30024608
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.
Webb AH; Gao BT; Goldsmith ZK; Irvine AS; Saleh N; Lee RP; Lendermon JB; Bheemreddy R; Zhang Q; Brennan RC; Johnson D; Steinle JJ; Wilson MW; Morales-Tirado VM
BMC Cancer; 2017 Jun; 17(1):434. PubMed ID: 28633655
[TBL] [Abstract][Full Text] [Related]
5. HOW EXPRESSIONS OF CLAUDIN-1 AND MMP-2 IN RETINOBLASTOMA CORRELATE WITH HISTOLOGICAL DIFFERENTIATION AND OPTIC NERVE INVASION.
Wan WC; Jin XM; Zheng GY; Zhang FY; Lv Y; Zhu Y
J Biol Regul Homeost Agents; 2015; 29(2):373-8. PubMed ID: 26122225
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical implication of Matrix Metalloproteinase-1 and Vascular Endothelial Growth Factor in retinoblastoma].
Yuan S; Song H
Yan Ke Xue Bao; 2010 Aug; 25(1):48-51. PubMed ID: 21166042
[TBL] [Abstract][Full Text] [Related]
8. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
Alkatan HM; AlQahtani FS; Maktabi AM
Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
[TBL] [Abstract][Full Text] [Related]
9. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O; Schlamp A; Broll R; Bruch HP
Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
[TBL] [Abstract][Full Text] [Related]
12. [Study on the risk factors for optic nerve invasion in 381 cases of retinoblastoma].
Ren RJ; Li B; Li LQ; Sun XL
Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):489-92. PubMed ID: 17897523
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
14. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
15. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Buhmeida A; Bendardaf R; Hilska M; Collan Y; Laato M; Syrjänen S; Syrjänen K; Pyrhönen S
J Gastrointest Cancer; 2009; 40(3-4):91-7. PubMed ID: 19921474
[TBL] [Abstract][Full Text] [Related]
17. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
[TBL] [Abstract][Full Text] [Related]
18. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma.
Ding J; Sun J; Ma RQ; Zheng K; Han YN
Int Ophthalmol; 2024 Mar; 44(1):133. PubMed ID: 38480634
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer.
Moser PL; Kieback DG; Hefler L; Tempfer C; Neunteufel W; Gitsch G
Anticancer Res; 1999; 19(5C):4391-3. PubMed ID: 10650781
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.
Bradley K; Scatizzi JC; Fiore S; Shamiyeh E; Koch AE; Firestein GS; Gorges LL; Kuntsman K; Pope RM; Moore TL; Han J; Perlman H
Arthritis Rheum; 2004 Jan; 50(1):78-87. PubMed ID: 14730602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
